You just read:

BioPact's MGMR® Drug Delivery Technology Succeeds In Mitigating Side Effects Of Doxorubicin While Retaining Anti-Cancer Efficacy In Lymphoma And Metastasis Mouse Models

News provided by

BioPact

Jun 14, 2017, 15:57 ET